IEQ Capital’s Ocular Therapeutix OCUL Stock Holding History

IEQ Capital’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$106K	Hold	12,532	–	–	﹤0.01%	1792
2025 Q4	$152K	Hold	12,532	–	–	﹤0.01%	1731
2025 Q3	$146K	Hold	12,532	–	–	﹤0.01%	1728
2025 Q2	$116K	Sell	12,532 -5,097	-29%	-$39.9K	﹤0.01%	1700
2025 Q1	$129K	Hold	17,629	–	–	﹤0.01%	1443
2024 Q4	$151K	Hold	17,629	–	–	﹤0.01%	1239
2024 Q3	$153K	Hold	17,629	–	–	﹤0.01%	1080
2024 Q2	$121K	Sell	17,629 -12,500	-41%	-$77.2K	﹤0.01%	945
2024 Q1	$274K	Hold	30,129	–	–	﹤0.01%	792
2023 Q4	$134K	Sell	30,129 -54,400	-64%	-$161K	﹤0.01%	870
2023 Q3	$265K	Hold	84,529	–	–	0.01%	760
2023 Q2	$436K	Hold	84,529	–	–	0.01%	578
2023 Q1	$445K	Sell	84,529 -55,000	-39%	-$261K	0.01%	610
2022 Q4	$392K	Sell	139,529 -144,404	-51%	-$478K	0.01%	563
2022 Q3	$1.18M	Hold	283,933	–	–	0.03%	328
2022 Q2	$1.14M	Sell	283,933 -124,000	-30%	-$468K	0.03%	288
2022 Q1	$2.02M	Hold	407,933	–	–	0.05%	206
2021 Q4	$2.84M	Sell	407,933 -221,049	-35%	-$1.72M	0.07%	155
2021 Q3	$6.29M	Buy	628,982 +49	+0%	+$550	0.17%	79
2021 Q2	$8.92M	Hold	628,933	–	–	0.26%	58
2021 Q1	$10.3M	Hold	628,933	–	–	0.43%	42
2020 Q4	$13M	Sell	628,933 -50,300	-7%	-$747K	0.58%	40
2020 Q3	$5.17M	Hold	679,233	–	–	0.28%	60
2020 Q2	$5.66M	Buy	679,233 +423,188	+165%	+$2.81M	0.37%	47
2020 Q1	$1.27M	Hold	256,045	–	–	0.1%	122
2019 Q4	$1.01M	Buy	+256,045	New	+$890K	0.09%	155

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IEQ Capital's OCUL Position: Q1 2026 in Review

IEQ Capital held its Ocular Therapeutix (OCUL) position steady in Q1 2026 at 12,532 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #1792.

IEQ Capital first reported a position in OCUL in Q4 2019 and has held it in 26 quarters since. The position peaked at $13M in Q4 2020. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

IEQ Capital held 12,532 shares of Ocular Therapeutix worth $106K as of Q1 2026.
IEQ Capital left its Ocular Therapeutix share count unchanged in Q1 2026.
Ocular Therapeutix made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1792 holding.
IEQ Capital first reported a position in Ocular Therapeutix in Q4 2019 and has held it in 26 quarters since.
IEQ Capital's Ocular Therapeutix position peaked at $13M in Q4 2020.
269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.